ABSTRACT. In the present study, the changes of gene expression profile in dendritic cell (DC)-derived DC2.4 cells sensitized with two allergenic chemicals were analyzed by microarray analysis to develop a basis for an in vitro assessment system of type IV allergenic chemicals. Consequently, 26 genes were significantly up-regulated, and 53 were down-regulated in both groups. Interestingly, some of upregulated genes were associated with the maturation process of DCs. A set of genes was further evaluated by real-time reverse transcription-polymerase chain reaction to identify the gene expression changes specifically induced by type IV allergy-inducible chemicals in DC2.4 cells, and 2 possible candidates, syndecan-1 (Sdc1) and smoothened (SMO) genes were identified. Thus, up-regulation of Sdc1 gene and down-regulation of SMO gene in DC2.4 cells may be diagnostic markers for the screening of type IV-allergenic chemicals. KEY WORDS: chemical, dendritic cell, microarray analysis, type IV allergy.
Allergic contact dermatitis (ACD), a type IV allergy, is one of the most common inflammatory diseases of the skin with unknown genetic basis and is often an occupationally related disorder in industrialized countries with an important socio-medical impact [14, 28] . At present, many chemicals are considered to have allergenic potency and thus risk assessment of such chemical substances is important. ACD has been intensively studied, and the development of an allergic hypersensitivity reaction in the skin is considered to be processes depending on the induction of specific T-lymphocyte responses [23] . At the initial step, chemical allergens exposed on the skin are recognized by Langerhans cells (LCs), the principal DC residing in the epidermis and known to play a key role in the development of ACD. Following an encounter with a chemical allergen, LCs are activated and subsequently migrate from the skin to the draining lymph nodes, undergoing a maturation process during the journey [20, 22] .
For many years, guinea pigs have been applied for the hazard analysis of skin-sensitizing chemicals [9, 26] . Recently, the local lymph node assay (LLNA) was developed in mice as an alternative approach based on the characterization of initial proliferative responses in draining lymph nodes caused by chemicals exposure [16, 21, 34, 39] , and this method is now widely used for estimation of the allergenic potency of chemical substances. Although these approaches are sensitive and reliable, more advantageous ways in terms of cost performance, safety, readiness and animal welfare are expected. More recently, in vitro assay for chemical substances with allergenic potency is extensively explored by using cultured cells, especially macrophages [5, 41] . In these experiments, up-regulation of several molecules including cell surface markers were reported to be induced by chemical exposure, suggesting that these markers may be candidates for evaluating chemicals with allergenic potency [5, 41] . However, as well documented, LCs, a family of DCs, are the main antigen presenting cell in the epidemis and have central roles on the induction of allergic skin disorders [4, 38] . In this regard, assessment of LC/ DC responses to chemical exposures should be reasonable to know accurate mechanisms of ACD development. Although several studies evaluated the effect of chemicals on DCs by use of in vitro differentiated primary DCs, it is disadvantageous because of the limited numbers in the source, donor-to-donor variability and cost for obtaining these cells.
In the present study, the changes of gene expression profile in an established DC line sensitized with allergenic chemicals were analyzed by microarray analysis and realtime reverse transcription-polymerase chain reaction (RT-PCR) to develop a basis for an in vitro assessment system of type IV allergy-inducible chemicals.
MATERIALS AND METHODS
Chemicals: Chemical substances, 2,4-dinitrochlorobenzene (DNCB; Wako Pure Chemical Industries, Osaka, Japan), p-benzoquinone (BQ; Kanto Chemical, Tokyo, Japan), citral (Cit; Nacalai Tesque, Kyoto, Japan), trimellitic anhydride (TMA; Kanto Chemical) and dextran (Dex; Kanto Chemical) were dissolved in DMSO to a concentration of 10 µg/ml as a stock solution and further diluted with cell culture medium for use. DNCB, BQ and Cit are known to be strong sensitizers and type IV allergy-inducible chemicals [15, 18, 24] . TMA is a respiratory sensitizer and a strong inducer of type I allergy. This chemical is also known as an irritant on the skin [10, 17] . Dex is reported to be a non-sensitizer on the skin [7, 39] .
Cells: The cell line DC2.4, derived from C57BL/6 mice, was kindly provided by Dr. Kenneth L. Rock (Division of Lymphocyte Biology, Dana Farber Cancer Institute, Boston, MA, U.S.A.). The DC2.4 cells have a dendritic morphology, express DC-specific markers, MHC molecules and costimulatory molecules, and have phagocytic activity as well as antigen-presenting capacity [35] . The cells were maintained in DMEM (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% fetal calf serum (FCS; Cansera International Inc., Ontario, Canada), 4 mM L-glutamine and 50 µM 2-mercaptoethanol at 37°C under 5% CO 2 in air. 
Sensitization of DC2.4 cells and

RESULTS
Sensitivity of DC2.4 cells to chemical exposures:
To determine the dose of chemicals for in vitro sensitization to DC-derived DC2.4 cells, the cells were exposed to various concentrations (0-100 µg/ml) of chemicals for 24 hr, and cell viabilities were determined by trypan blue dye exclusion assay. The viability of DC2.4 cells was largely affected when exposed to DNCB, BQ and Cit at the concentration of 5-10 µg/ml although their cytotoxicity was low at 1-5 µg/ ml and almost background level at 0-0.5 µg/ml. On the other hand, the effect of TMA or Dex on the viability of DC2.4 cells was minimal through the examined concentrations (0-100 µg/ml) (Fig. 1 ). Based on these findings, we decided to use these chemicals at the concentration of 0.1 µg/ml on DNCB, BQ and Cit, and 1.0 µg/ml on TMA and Dex for subsequent experiments.
Microarray analysis of gene expression changes in DC2.4 cells induced by chemical exposures:
To determine the typical gene expression changes in DC2.4 cells induced by type IV allergenic chemical exposure, DC2.4 cells were exposed to DNCB or BQ, both of which are known as strong sensitizers of contact hypersensitivity, for 24 hr and subjected to cDNA microarray analysis. In the DNCB-treated DC2.4 cells, 957 genes were up-regulated with fold changes of +1.3 to +4.4 and 1933 genes were down-regulated with fold changes of -1.3 to -9.0 when compared with control samples. On the other hand, in the BQ-treated cells, 790 genes had fold increases in expression over control ranging from +1.3 to +3.9, and 726 genes showed a down-regulation with fold changes of -1.3 to -2.2. When we overlapped these two data, 26 genes were up-regulated, and 53 were down-regulated in both groups. The changed genes represented a wide range of cellular processes including signal transduction, protein modification/synthesis and transcription. A list of genes which were up-regulated in DC2.4 cells after exposure to DNCB or BQ for 24 hr are presented in Table 2 along with their accession number and fold-change relative to the control cell cultures. The genes down-regulated are also shown in Table 3 .
Real-time RT-PCR analyses of gene expression changes in DC2.4 cells induced by chemical exposures:
In order to determine the reproducibility of the gene expression changes observed in microarray analysis, a set of genes was selected for evaluation by real-time RT-PCR. In the previous study, we assessed in vivo changes of gene expression in mouse ear sensitized with a type IV allergy-inducible chemical, BQ (data not shown). The microarray data from DNCB or BQ-treated DC2.4 cells were compared with that from type IV chemical-exposed mouse ears, and up-or down-regulated genes in all the experiments were explored. As the result, 3 up-regulated (Socs2, Sdc1 and Tuba6) and 8 downregulated (Eps8, Exo1, Asah2, Cpd, LY86, SMO, Hey1 and Pik3c2a) genes showed strict changes in all the experiments, and thus these genes were subjected to further real-time RT-PCR analysis. The real-time RT-PCR results showed that all up-regulated genes and 6 of 8 down-regulated ones corresponded to microarray analysis data although Sdc1 and Pik3c2a showed only limited changes when compared with microarray analysis data (Fig. 2) .
To determine whether any of the significant gene changes observed were due to the reactive nature of the contact allergen, DC2.4 cells were exposed to 1.0 µg/ml DMSO (solvent used to dissolve chemicals as a control), 0.1 µg/ml BQ (a type IV allergy-inducible chemical), 0.1 µg/ml Cit (a type IV allergy-inducible chemical), 1.0 µg/ml TMA (an irritant on the skin and a type I allergy inducer) and 1.0 µg/ml Dex (a non-sensitizer on the skin) for 24 hr, and gene expression changes were determined by real-time RT-PCR. As shown in Fig. 2 , all 3 up-regulated genes chosen were enhanced, and the 8 down-regulated genes were diminished their expression by BQ-or Cit-treatment for 24 hr although some genes such as Tuba6 and Cpd showed limited changes. When treated with TMA, enhanced expression of LY86 and SMO genes, which are down-regulated after type IV allergy-inducible chemicals, was observed (Fig. 2) . Socs2 gene, which was up-regulated after sensitization by type IV allergy-inducible chemicals, was also up-regulated by the TMA-treatment, while the expression levels of other genes were scarcely affected by TMA (Fig. 2) . In case of Dextreated cells, the changes of gene expression levels were seen on some genes; up-regulation of SMO and down-regulation of Sdc1, Eps8, Exo1, Asah2, Hey1 and Pik3c2a (Fig.  2) . From these results, up-regulation of Sdc1 gene and down-regulation of SMO gene in DC2.4 cells may be specific for type IV-allergy inducible chemicals.
DISCUSSION
In the present study, we focused on the induction phase of type IV allergy and attempted to identify the genes specifically changed by type IV allergy-inducible chemicals in DCs. For this purpose, changes of gene expression profile in DCs to hapten exposure were evaluated by microarray analysis, since LCs, a family of DCs, were shown to have central roles on the initiation of immune responses including allergic reactions in the skin [4, 38] . Recently, attempts have been made to develop in vitro sensitization tests using DCs derived from peripheral blood mononuclear cells or CD34 + hematopoietic progenitor cells purified from cord blood or bone marrow [1, 36] . However, the use of in vitro differentiated primary DCs is difficult due to the nature of these cells such as low numbers in the source and donor-todonor variability [2] . In addition, treatment with several cytokines is generally applied to obtain DCs from blood or bone marrow cells [3, 11, 30] , and this process probably changes the cell reactivity to stimulations. Thus, established cell lines are preferable to standardize the condition among assay. A recently established DC line, DC2.4 cells, was applied as a target cell for this assay, and its reactivity to chemical exposures was addressed by microarray analysis. As the result, many gene expression changes were observed after treatment with two different allergenic chemicals, DNCB and BQ. Overall, the changes seemed to be not so noticeable. It is because of the nature of this cell line since the human monocyte-derived THP-1 cells with the same treatment extensively changed a large number of gene expression profile (data not shown). In addition, similar results to our data were reported in a recent study using primary DCs from peripheral blood after chemical treatment [31, 36, 37] , suggesting that the effect of sensitization on the gene expression levels might be relatively mild in DC lineage. We analyzed the two data from DNCB-and BQ-sensitized cells and tried to line up the candidate genes specifically up-or down-regulated by type IV allergyinducible chemicals. As the results, 26 genes were shown to be up-regulated, and 53 were down-regulated in both groups. Interestingly, some of up-regulated genes were associated with the maturation process of DCs. These include TNF-α (a maturation-inducing cytokine), Sdc-1 (a cell surface proteoglycan induced during the maturation process), Map2k4 (a member of MAP kinase kinase family associated with migration and maturation of DC) and Socs2 (a suppressor of cytokine signaling molecule induced during the maturation process) [12, 19, 40] . In addition, up-regulation was also detected on defensin and cathelin, which were formerly considered to work just as antimicrobial peptides [6, 8] and recently reported to have cell migration activity and to be associated with DC maturation process [25] . In contrast, down-regulation of CD44 was detected, which is reported to be expressed on mature DC and induce adhesion with T cell. This may be explained by that the time point at 24 hr after sensitization is still in the process of maturation.
In the previous studies, many other molecules are reported to be associated with DC maturation process; for instance, up-regulation of transcripts for the co-stimulatory molecules CD86 [29] and the constitutive chemokine receptor CXCR4 [32, 33] , and down-regulation of genes encoding molecules involved in antigen uptake such as the high affinity IgE receptor [27] , aquaporin 3 [13] . However, the changes of these molecules were not observed in our study. Assessments of gene expression changes in other time points may detect the up-or down-regulation of these genes. Alternatively, characteristics of DC2.4 cells may give rise to the results. In order to determine the reproducibility of the gene expression changes observed by microarray analysis, the data from DNCB or BQ-treated DC2.4 cells were compared with that from type IV chemical-exposed mouse ears (data not shown), and 3 up-regulated (Socs2, Sdc1 and Tuba6) and 8 down-regulated (Eps8, Exo1, Asah2, Cpd, LY86, SMO, Hey1 and Pik3c2a) genes in all the experiments were selected for further evaluation by real-time RT-PCR. DC2.4 cells were treated with TMA, an irritant on the skin and type I allergy inducer, and Dex, a non-hazardous chemical on the skin, in addition to type IV allergy inducers, DNCB, BQ and Cit, to identify contact hypersensitivity-specific changes. Although DNCB-induced up-regulation of Sdc1 gene is limited, other type IV allergy inducible chemicals, BQ and Cit, markedly up-regulated the gene expression as seen in microarray experiments in DNCB or BQ-exposed DC2.4 cells and DNCB-treated mouse tissues. TMA, an irritant on the skin and type I allergy inducer, also up-regulated Sdc1 gene expression in some experiment; however, the changes are neither significant nor reproducible. Thus, these results suggested that up-regulation of Sdc1 gene and especially, down-regulation of SMO gene in DC2.4 cells correlated with type IV allergic reaction (Fig. 2) . In the experiment, Dex-treatment induced expression changes of Sdc1, Eps8, Exo1, Asah2, Hey1 and Pik3c2a genes (Fig. 2) . Dex is known as a non-sensitizer on the skin; however, we suspected that it had some stimulatory effects on the cells when sensitized directly. Alternatively, uptake of such a high molecular compound with molecular mass of 60,000-90,000 probably initiated DC activation in vitro. At present, the function of the proteins derived from Sdc1 and SMO genes on DCs was not well documented although Sdc1 was shown to be a cell surface proteoglycan induced during the maturation process. Further functional analyses may bring interesting information about the role of these proteins on DC maturation and initiation of type IV allergic reaction.
In conclusion, we tried to identify the gene expression changes specifically induced by type IV allergy-inducible chemicals in DCs by microarray and real-time RT-PCR analyses, and 2 possible candidates, Sdc1 and SMO genes, were identified. Thus, up-regulation of Sdc1 gene and down-regulation of SMO gene in DC2.4 cells may be diagnostic markers for the screening of type IV-allergy inducible chemicals. Further analyses of the genes specifically changed by type IV allergy-inducible chemicals are required to clarify the gene expression profiles. The combination of expression changes on several candidate genes may promise reliable results for screening of the allergic chemicals.
